IDIndonesian Health Minister Budi Gunadi Sadikin announced a goal to achieve full domestic production of 15 vaccine antigens used in the national immunization program by 2029. Currently, only four of these antigens are produced locally, while others rely on imported active pharmaceutical ingredients from China and India, with local companies handling the final formulation. Sadikin emphasized the need to develop key technologies such as mRNA and viral vector methods, which Indonesia currently lacks, and called for collaboration between academia, industry, and government agencies to accelerate vaccine self-sufficiency. He highlighted the importance of translating scientific research into practical medical solutions that benefit society and save lives.
Bias read (Center): The article presents the minister's policy goals and calls for collaboration without overtly endorsing or criticizing specific political factions. While the subject matter is politically significant due to its implications for national healthcare strategy and economic independence, the framing is ap
